187 related articles for article (PubMed ID: 37494669)
1. Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment.
Green SMC; Hall LH; French DP; Rousseau N; Parbutt C; Walwyn R; Smith SG
Ann Behav Med; 2023 Oct; 57(11):988-1000. PubMed ID: 37494669
[TBL] [Abstract][Full Text] [Related]
2. Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial.
Green SMC; Hall LH; Rousseau N; French DP; Graham CD; Collinson M; Mason E; Wilkes H; Howdon D; Foy R; Walwyn R; Clark J; Parbutt C; Raine E; Ellison R; Buxton J; Moore SJL; Velikova G; Farrin A; Smith SG
NIHR Open Res; 2023; 3():3. PubMed ID: 37881449
[TBL] [Abstract][Full Text] [Related]
3. Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy.
Green SMC; French DP; Graham CD; Hall LH; Rousseau N; Foy R; Clark J; Parbutt C; Raine E; Gardner B; Velikova G; Moore SJL; Buxton J; ; Smith SG
BMC Health Serv Res; 2022 Aug; 22(1):1081. PubMed ID: 36002831
[TBL] [Abstract][Full Text] [Related]
4. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
[TBL] [Abstract][Full Text] [Related]
5. Sociodemographic, clinical, psychosocial, and healthcare-related factors associated with beliefs about adjuvant endocrine therapy among breast cancer survivors.
Sutton AL; Salgado TM; He J; Hurtado-de-Mendoza A; Sheppard VB
Support Care Cancer; 2020 Sep; 28(9):4147-4154. PubMed ID: 31897782
[TBL] [Abstract][Full Text] [Related]
6. Facilitators and barriers to medication adherence with adjuvant endocrine therapy in women with breast cancer: a structural equation modelling approach.
Tan EH; Wong ALA; Tan CC; Wong P; Tan SH; Ang LEY; Lim SE; Chong WQ; Ho J; Lee SC; Tai BC
Breast Cancer Res Treat; 2021 Aug; 188(3):779-788. PubMed ID: 33948777
[TBL] [Abstract][Full Text] [Related]
7. Refining and optimising a behavioural intervention to support endocrine therapy adherence (ROSETA) in UK women with breast cancer: protocol for a pilot fractional factorial trial.
Smith SG; Green SMC; Ellison R; Foy R; Graham CD; Mason E; French DP; Hall LH; Wilkes H; McNaught E; Raine E; Walwyn R; Howdon D; Clark J; Rousseau N; Buxton J; Moore SJL; Parbutt C; Velikova G; Farrin A; Collinson M
BMJ Open; 2023 Feb; 13(2):e069971. PubMed ID: 36737093
[TBL] [Abstract][Full Text] [Related]
8. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
[TBL] [Abstract][Full Text] [Related]
9. The role of trust in the acceptance of adjuvant endocrine therapy in breast cancer patients.
Constanze E; Uwe G; Christoph T; Kavitha D; Dominik R; Urte S; Walter B
Psychooncology; 2022 Dec; 31(12):2122-2131. PubMed ID: 36251608
[TBL] [Abstract][Full Text] [Related]
10. Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
Lambert LK; Balneaves LG; Howard AF; Chia SK; Gotay CC
BMC Cancer; 2018 Jul; 18(1):732. PubMed ID: 29996816
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Pilot Trial of a Low-Touch Remotely-Delivered Values Intervention to Promote Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors.
Arch JJ; Crespi CM; Levin ME; Genung SR; Nealis M; Mitchell JL; Bright EE; Albright K; Magidson JF; Stanton AL
Ann Behav Med; 2022 Aug; 56(8):856-871. PubMed ID: 35323853
[TBL] [Abstract][Full Text] [Related]
12. Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial.
Walsh EA; Post K; Massad K; Horick N; Antoni MH; Penedo FJ; Safren SA; Partridge AH; Peppercorn J; Park ER; Temel JS; Greer JA; Jacobs JM
Breast Cancer Res Treat; 2024 Apr; 204(3):547-559. PubMed ID: 38231313
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.
Toledo G; Ochoa CY; Farias AJ
Support Care Cancer; 2020 Jan; 28(1):271-278. PubMed ID: 31037379
[TBL] [Abstract][Full Text] [Related]
14. The relationship between medication adherence and illness perception in breast cancer patients with adjuvant endocrine therapy: beliefs about medicines as mediators.
Zhao M; Zhao J; Chen J; Li M; Zhang L; Luo X; Zhang Y; Xiong C; Guo Z; Yan J
Support Care Cancer; 2022 Dec; 30(12):10009-10017. PubMed ID: 36261611
[TBL] [Abstract][Full Text] [Related]
15. A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.
Jacobs JM; Post K; Massad K; Horick NK; Walsh EA; Cohn J; Rapoport CS; Clara AJ; Antoni MH; Safren SA; Partridge AH; Peppercorn JM; Park ER; Temel JS; Greer JA
Cancer; 2022 Oct; 128(19):3541-3551. PubMed ID: 35924869
[TBL] [Abstract][Full Text] [Related]
16. The experiences of adjuvant endocrine therapy for women breast cancer survivors: A literature review.
Long Y; Xie S; Liu Q; Xu F; Li Q; Wang N; Zhang Y
Medicine (Baltimore); 2023 Dec; 102(51):e36704. PubMed ID: 38134074
[TBL] [Abstract][Full Text] [Related]
17. Beliefs and attitudes toward endocrine therapy in patients with hormone receptor-positive breast cancer.
Kim Y; Min YH; Lee SB
Health Care Women Int; 2021 Sep; 42(7-9):1086-1097. PubMed ID: 32886576
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors.
Bright EE; Finkelstein LB; Nealis MS; Genung SR; Wrigley J; Gu HCJ; Schmiege SJ; Arch JJ
J Clin Oncol; 2023 Oct; 41(28):4548-4561. PubMed ID: 37531593
[TBL] [Abstract][Full Text] [Related]
19. Beliefs about medicines' association with endocrine therapy adherence in early breast cancer survivors in Croatia.
Okroša AD; Silovski T; Plavetić ND; Silovski H; Kovačić A; Mucalo I
Acta Pharm; 2023 Dec; 73(4):673-689. PubMed ID: 38147479
[TBL] [Abstract][Full Text] [Related]
20. Systematic adaptation of the adherence improving self-management strategy to support breast cancer survivors' adherence to adjuvant endocrine therapy: An intervention mapping approach.
Janssen AM; Dam J; Prins J; Buffart LM; de Bruin M
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13721. PubMed ID: 36263723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
